Fatty liver disease, increasingly prevalent among young individuals, stems from unhealthy diets, sedentary lifestyles, and ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

As diabetes rates soar in India, those over 40 face increased heart disease risks. Early intervention, healthy habits, and ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin ...

Considered a disease of middle-aged and older adults until the late 20th century, type 2 diabetes has risen markedly ...

Objectives To explore experiences of UK-based South Asian and White patients with diabetes in relation to their support systems for and barriers to diabetes management. Design Qualitative study ...

This June, like every other, has been filled with talk of graduations, the scent of barbecue and Fathers' Day sales. But amid ...

Research shows that increased fruit consumption is associated with reduced abdominal fat in children, highlighting its ...